Found: 38
Select item for more details and to access through your institution.
Issue Information.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1053, doi. 10.1111/apt.17009
- Publication type:
- Article
Available modalities for screening and imaging diagnosis of hepatocellular carcinoma--Current gaps and challenges.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1056, doi. 10.1111/apt.17506
- By:
- Publication type:
- Article
Practical considerations for fluid resuscitation in cirrhosis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1066, doi. 10.1111/apt.17458
- By:
- Publication type:
- Article
Prevalence and impact of faecal incontinence among individuals with Rome IV irritable bowel syndrome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1083, doi. 10.1111/apt.17465
- By:
- Publication type:
- Article
Adverse effect of PNPLA3 p.I148M genetic variant on kidney function in middle-aged individuals with metabolic dysfunction.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1093, doi. 10.1111/apt.17477
- By:
- Publication type:
- Article
Trends in risk factor control and treatment among patients with non-alcoholic fatty liver disease and type 2 diabetes between 2000 and 2020: A territory-wide study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1103, doi. 10.1111/apt.17428
- By:
- Publication type:
- Article
Safety of an investigational formulation of budesonide (budesonide oral suspension) for eosinophilic oesophagitis: an integrated safety analysis of six phase 1-3 clinical trials.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1117, doi. 10.1111/apt.17430
- By:
- Publication type:
- Article
Mitochondrial respiratory chain activity is associated with severity, corticosteroid response and prognosis of alcoholic hepatitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1131, doi. 10.1111/apt.17434
- By:
- Publication type:
- Article
Longitudinal association between overweight years, polygenic risk and NAFLD, significant fibrosis and cirrhosis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1143, doi. 10.1111/apt.17452
- By:
- Publication type:
- Article
should NAFLD be included in the definition of Metabolic Syndrome?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1151, doi. 10.1111/apt.17411
- By:
- Publication type:
- Article
concurrence of coeliac disease with inflammatory bowel disease -is big data the final arbiter?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1153, doi. 10.1111/apt.17425
- By:
- Publication type:
- Article
concurrence of coeliac disease with inflammatory bowel disease -is big data the final arbiter? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1155, doi. 10.1111/apt.17436
- By:
- Publication type:
- Article
mitochondrial respiratory chain activity--a potential link with disease severity and treatment response in alcoholic hepatitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1157, doi. 10.1111/apt.17440
- By:
- Publication type:
- Article
mitochondrial respiratory chain activity--a potential link with disease severity and treatment response in alcoholic hepatitis. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1159, doi. 10.1111/apt.17469
- By:
- Publication type:
- Article
safety of topical steroids designed specifically for eosinophilic oesophagitis-new data bring new questions.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1161, doi. 10.1111/apt.17442
- By:
- Publication type:
- Article
safety of topical steroids designed specifically for eosinophilic oesophagitis -new data bring new questions. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1163, doi. 10.1111/apt.17476
- By:
- Publication type:
- Article
"being normal weight each day keeps NAFLD and fibrosis away"--the importance of reducing cumulative exposure to overweight.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1166, doi. 10.1111/apt.17460
- By:
- Publication type:
- Article
"being normal weight each day keeps NAFLD and fibrosis away"--the importance of reducing cumulative exposure to overweight. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1168, doi. 10.1111/apt.17478
- By:
- Publication type:
- Article
improvement of cardiovascular risk factor control in patients with type 2 diabetes and nonalcoholic fatty liver disease--time for action!
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1170, doi. 10.1111/apt.17467
- By:
- Publication type:
- Article
improvement of cardiovascular risk factor control in patients with type 2 diabetes and nonalcoholic fatty liver disease--time for action! Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1172, doi. 10.1111/apt.17474
- By:
- Publication type:
- Article
faecal incontinence is prevalent in IBS, as are effective treatment options!
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1174, doi. 10.1111/apt.17486
- By:
- Publication type:
- Article
faecal incontinence is prevalent in IBS, as are effective treatment options! Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1176, doi. 10.1111/apt.17494
- By:
- Publication type:
- Article
empirical pharmacological management of gastroparesis--a cautionary tale.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1178, doi. 10.1111/apt.17499
- By:
- Publication type:
- Article
NAFLD, chronic kidney disease, and pleiotropy--Why is PNPLA3 omnipresent?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1180, doi. 10.1111/apt.17491
- By:
- Publication type:
- Article
5-aminosalicylate maintenance treatment in mild Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1183, doi. 10.1111/apt.17489
- By:
- Publication type:
- Article
5-aminosalicylate maintenance treatment in mild Crohn's disease--authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1184, doi. 10.1111/apt.17504
- By:
- Publication type:
- Article
higher severe outcomes among Helicobacter pylori-related lean patients with non-alcoholic fatty liver disease and metabolic comorbidities.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1186, doi. 10.1111/apt.17484
- By:
- Publication type:
- Article
Does irritable bowel syndrome have a greater impact in Western, compared with Asian, patients?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1188, doi. 10.1111/apt.17485
- By:
- Publication type:
- Article
Does irritable bowel syndrome have a greater impact in Western, compared with Asian, patients? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1190, doi. 10.1111/apt.17497
- By:
- Publication type:
- Article
fulminant-onset complicated inflammatory bowel disease (IBD)--a unique subtype?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1192, doi. 10.1111/apt.17418
- By:
- Publication type:
- Article
fulminant onset complicated inflammatory bowel disease (IBD) -a unique subtype? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1194, doi. 10.1111/apt.17445
- By:
- Publication type:
- Article
Potassium-competitive acid blockers may increase the risk of gastric cancer after Helicobacter pylori eradication a retrospective multicentre-cohort analysis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1196, doi. 10.1111/apt.17461
- By:
- Publication type:
- Article
Potassium-competitive acid blockers may increase the risk of gastric cancer after Helicobacter pylori eradication--a retrospective multicentre-cohort analysis. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1199, doi. 10.1111/apt.17480
- By:
- Publication type:
- Article
to expand the diagnosis and scale up treatment for patients with chronic hepatitis B--difficult but necessary.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1201, doi. 10.1111/apt.17470
- By:
- Publication type:
- Article
diagnostic delay in inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1203, doi. 10.1111/apt.17483
- By:
- Publication type:
- Article
diagnostic delay in inflammatory bowel disease--Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1205, doi. 10.1111/apt.17493
- By:
- Publication type:
- Article
deciphering the complexities of chronic liver disease epidemiology through a directed acyclic graph (DAG).
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1207, doi. 10.1111/apt.17427
- By:
- Publication type:
- Article
time to consider Pneumocystis jirovecii pneumonia prophylaxis in treatment of autoimmune hepatitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1210, doi. 10.1111/apt.17508
- By:
- Publication type:
- Article